|
|
Article: MIV Therapeutics to Begin First Human Implants As Other Companies With Nanotechnolgy Interests Provide Latest News on Publication Information, Mergers, Distribution and Awards.
- Article from:
- M2 Presswire
- Article date:
- October 30, 2006
|
Copyright informationCOPYRIGHT 2006 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-30 October 2006-Stockguru.com: MIV Therapeutics to Begin First Human Implants As Other Companies With Nanotechnolgy Interests Provide Latest News on Publication Information, Mergers, Distribution and Awards(C)1994-2006 M2 COMMUNICATIONS LTD
RDATE:30102006
Dallas, Texas - StockGuru Pre-Market Updates for Monday include MIV Therapeutics Inc. (OTCBB: MIVT), Nanobac Pharmaceuticals Inc. (OTCBB: NNBP), mPhase Technologies (OTCBB: XDSL), Industrial Nanotech, Inc. (OTC: INTK), Sono-Tek Corporation (OTCBB: SOTK), and Third-Order Nanotechnologies, Inc. (OTC: TDON)
StockGuru Alerts feature companies with significant corporate news within the last seven days. In ...
Related newspaper, magazine, and journal articles:
|
|
Article: MIV Therapeutics Cancels Endovasc License Agreement.
PR Newswire;
May 23, 2003 ;
395 words
...MIV Therapeutics Inc. (MIVT:OTCBB) has announced it will not extend...continue our working relationship in the future. About MIV Therapeutics MIV Therapeutics is developing a next generation line of advanced...equal partner in Stentgenix Inc., a Joint Venture company developing ...
|
|